Neurobehavioral Disorders
An additional 53.2 million cases of major depressive disorder and 76.2 million cases of anxiety disorders globally were estimated due to the COVID-19 pandemic.
Neurobehavioral Disorders
Researchers compared the effects of 4 contemporary ablative neurosurgical procedures on treatment-resistant psychiatric symptoms.
Neurobehavioral Disorders
Use of ketamine and esketamine for their antidepressant effects does not seem to have harmful neurocognitive effects in individuals with treatment-resistant depression.
Neurobehavioral Disorders
The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to targeted areas of the brain.
Neurobehavioral Disorders
The FDA has cleared Nexstim's NBT system for the treatment of major depressive disorder.
Neurobehavioral Disorders
HIV-infected adults with major depressive disorder have a 30% increased risk for acute myocardial infarction.
Neurobehavioral Disorders
The influence of gut microbiota extends to the brain via neuroinflammation, resulting in symptoms associated with major depressive disorder.
Neurobehavioral Disorders
Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.
Neurobehavioral Disorders
Researchers conducted a study to evaluate the validity of, and satisfaction with, the Cognition KIT DSST mobile app in patients with major depressive disorder.
Neurobehavioral Disorders
More than half of individuals with prior COVID-19 illness have met the criteria for symptoms of major depressive disorder.
